Logo

ODD

Oddity Tech Ltd.

ODD

Oddity Tech Ltd. • NASDAQ
$43.26 ▲ 0.51% (+0.22)
Market Cap $2.45 B
52w High $79.18
52w Low $35.30
Dividend Yield 0%
P/E 24.17
Volume 401.07K
Outstanding Shares 56.66M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $147.902M ▼ $88.526M ▼ $17.745M ▼ 11.998% ▼ $0.31 ▼ $26.233M ▼
Q2-2025 $241.14M ▼ $117.258M ▼ $49.285M ▲ 20.438% ▲ $0.87 ▲ $62.24M ▲
Q1-2025 $268.076M ▲ $158.183M ▲ $37.831M ▲ 14.112% ▲ $0.68 ▲ $45.32M ▲
Q4-2024 $123.64M ▲ $85.844M ▲ $5.298M ▼ 4.285% ▼ $0.094 ▼ $6.706M ▼
Q3-2024 $118.998M $63.698M $17.719M 14.89% $0.31 $22.1M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $639.71M ▼ $1.109B ▲ $728.45M ▼ $380.684M ▲
Q2-2025 $678.679M ▲ $1.098B ▲ $746.664M ▲ $351.235M ▲
Q1-2025 $186.659M ▲ $534.241M ▲ $204.505M ▲ $329.736M ▲
Q4-2024 $100.22M ▼ $438.882M ▼ $156.578M ▲ $282.304M ▼
Q3-2024 $147.637M $505.789M $145.745M $360.044M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $17.745M ▼ $-8.85M ▼ $-43.247M ▼ $-12.508M ▼ $-64.827M ▼ $-9.856M ▼
Q2-2025 $49.285M ▲ $13.048M ▼ $-35.655M ▼ $542.421M ▲ $519.962M ▲ $12.099M ▼
Q1-2025 $37.831M ▲ $88.336M ▲ $-3.961M ▼ $1.931M ▲ $86.59M ▲ $85.874M ▲
Q4-2024 $5.298M ▼ $16.165M ▲ $36.418M ▲ $-88.028M ▼ $-35.736M ▼ $13.977M ▼
Q3-2024 $17.719M $16.159M $20.452M $-37.56M $-902K $14.13M

Five-Year Company Overview

Income Statement

Income Statement Oddity’s income statement shows a young company scaling very quickly while staying consistently profitable. Revenue has increased strongly every year, and profits have grown even faster, suggesting good operating leverage as the business gets larger. Gross margins look high for a consumer-facing company, reflecting a mix of premium pricing, direct-to-consumer distribution, and a digital-first model. The steady rise in operating and net income points to disciplined cost control, though the sharp jump in earnings per share around the IPO period may also reflect changes in share count and accounting, not just underlying performance. Overall, the historical trend is of a fast-growing, already-profitable platform rather than a cash-burning tech story.

Balance Sheet

Balance Sheet The balance sheet looks relatively clean and conservative for a high-growth tech-enabled business. Total assets have expanded meaningfully as the company has grown, while equity has risen at a healthy pace, indicating that earnings are being retained to support growth. Debt levels appear modest, suggesting limited financial leverage and lower balance-sheet risk. Cash balances are positive but not large relative to the pace of growth, so the company still needs ongoing strong cash generation or access to capital markets to fund ambitious plans. In short, the financial structure is sound but still in a “building” phase rather than mature and cash-heavy.

Cash Flow

Cash Flow Cash flow trends reinforce the picture of a scalable, asset-light model. Operating cash flow has been positive for several years and is growing, which means reported profits are translating reasonably well into actual cash. Capital spending has remained modest, so free cash flow has improved along with earnings, a good sign for a digital-first company that doesn’t require heavy physical investment. This gives Oddity some internal funding capacity for marketing, product development, and technology investments. The main watchpoint is whether cash generation can keep pace with more capital-intensive bets such as labs, telehealth expansion, and new brand launches.

Competitive Edge

Competitive Edge Oddity sits at the intersection of technology, beauty, and wellness, competing less like a traditional cosmetics company and more like a data-driven consumer platform. Its direct-to-consumer model gives it direct relationships with customers, better data, and more control over pricing and experience than brands that rely on retailers. The company’s “data moat” – built from detailed quizzes, imaging, and user behavior across millions of customers – makes its personalization engine and recommendation quality hard to copy quickly. At the same time, it faces intense competition from global beauty giants, emerging digital-native brands, and rising customer acquisition costs in online marketing. Its advantage will depend on sustaining superior personalization, brand desirability, and efficient marketing as competitors try to catch up technologically.

Innovation and R&D

Innovation and R&D Innovation is at the core of Oddity’s strategy and is broader than typical beauty brand development. The company uses AI, machine learning, and proprietary data platforms to power personalized product matching and diagnostics, which directly tie technology to revenue. ODDITY LABS pushes further into science-based differentiation by using AI to discover new cosmetic and wellness molecules, aiming to launch proprietary ingredients into its product lines over the next few years. METHODIQ expands the platform into tele-dermatology, blending medical services with product recommendations and opening the door to broader telehealth offerings. These initiatives could deepen the moat and diversify revenue, but they also increase execution risk, regulatory complexity, and the need for sustained investment in R&D and technology talent.

Summary

Oddity Tech combines the growth profile of a successful consumer brand group with the tools and mindset of a software and data company. Its financial history shows rapid revenue expansion alongside solid profitability and cash generation, which is unusual for a company this young and growth-focused. The balance sheet is relatively low in debt and supported by growing equity, though not yet overflowing with cash, reflecting an early-stage yet financially disciplined business. Strategically, its edge comes from owning customer data, delivering personalization at scale, and integrating science, AI, and telehealth into the beauty and wellness journey. Looking ahead, the key opportunities lie in new brands, proprietary ingredients, and platform partnerships, while the main risks involve competitive pressure, marketing efficiency, regulatory issues in health-related offerings, and the challenge of successfully executing on an ambitious innovation roadmap.

NEWS

November 19, 2025 · 4:05 PM UTC

ODDITY Tech Reports Record Third Quarter Results, Raises Full Year Outlook

Read more

November 18, 2025 · 9:00 AM UTC

ODDITY Launches METHODIQ, a Telehealth Platform Reimagining Medical Care

Read more

October 22, 2025 · 4:30 PM UTC

ODDITY to Announce Third Quarter 2025 Financial Results on November 19, 2025

Read more